MILL BANK — All Prescriptions & Medications — Page 12
Practice Code: M83057 | STAFFORD, ST16 2AG
Showing results 551-600 of 641
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Loteprednol etabonate | 16 | 80 | £84 | +73.0% ▲ |
| 16 | 170 | £349 | -42.2% ▼ | |
| 16 | 347 | £414 | -37.0% ▼ | |
| 16 | 16 | £18 | -39.5% ▼ | |
| 16 | 41 | £250 | -9.8% ▼ | |
| 16 | 50 | £2.3K | +94.3% ▲ | |
| 16 | 34 | £649 | +22.4% ▲ | |
| 16 | 540 | £274 | -28.3% ▼ | |
| 16 | 1,680 | £329 | +54.9% ▲ | |
| 16 | 300 | £1.5K | +14.4% ▲ | |
| 16 | 480 | £715 | +145.9% ▲ | |
| Prazosin hydrochloride | 15 | 1,800 | £77 | -10.9% ▼ |
| Mebendazole | 15 | 186 | £16 | +31.0% ▲ |
| Cabergoline | 15 | 120 | £211 | -3.3% ▼ |
| Powder micronutrient supplement (0913291) | 15 | 8,800 | £1.1K | +88.7% ▲ |
| Triamcinolone acetonide | 15 | 15 | £105 | +46.4% ▲ |
| 15 | 170 | £311 | -46.1% ▼ | |
| 15 | 710 | £76 | +46.7% ▲ | |
| Co-tenidone (Atenolol/chlortalidone) | 14 | 672 | £141 | -32.9% ▼ |
| Colestyramine | 14 | 560 | £174 | -51.4% ▼ |
| Glycopyrronium bromide | 14 | 420 | £366 | -62.4% ▼ |
| Buspirone hydrochloride | 14 | 1,176 | £140 | -72.2% ▼ |
| Rifaximin | 14 | 737 | £3.4K | -47.9% ▼ |
| Goserelin acetate | 14 | 14 | £1.1K | -68.2% ▼ |
| Ready to serve 1 kcal/ml milkshake lower energy (0913021) | 14 | 216.0K | £4.1K | +39.6% ▲ |
| Piroxicam | 14 | 398 | £161 | +104.7% ▲ |
| 14 | 490 | £366 | -65.5% ▼ | |
| 14 | 1,360 | £69 | -65.8% ▼ | |
| Formoterol fumarate | 13 | 13 | £306 | -9.3% ▼ |
| Mometasone/glycopyrronium/indacaterol | 13 | 390 | £550 | -14.2% ▼ |
| Hyoscine hydrobromide | 13 | 784 | £130 | -61.9% ▼ |
| Midazolam hydrochloride | 13 | 46 | £1.0K | -9.8% ▼ |
| Ertugliflozin | 13 | 364 | £363 | -27.9% ▼ |
| Tibolone | 13 | 1,792 | £159 | -57.5% ▼ |
| Solifenacin/tamsulosin | 13 | 390 | £341 | -36.7% ▼ |
| Magnesium glycerophosphate | 13 | 672 | £445 | -5.4% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 13 | 120.0K | £3.1K | -5.8% ▼ |
| Powder essential fatty acid supplement (0913212) | 13 | 388 | £789 | +41.2% ▲ |
| Pdr disc/non ACBS protein SfI metabolic condition (0913445) | 13 | 7,800 | £5.2K | +101.7% ▲ |
| Etodolac | 13 | 364 | £180 | -53.0% ▼ |
| Betaxolol | 13 | 65 | £24 | +36.7% ▲ |
| Fluocinolone acetonide | 13 | 600 | £98 | +19.4% ▲ |
| 13 | 248 | £255 | -59.8% ▼ | |
| 13 | 206 | £101 | -64.9% ▼ | |
| 13 | 162 | £336 | -4.7% ▼ | |
| 13 | 20 | £882 | +49.3% ▲ | |
| 13 | 1,300 | £185 | -66.6% ▼ | |
| Dicycloverine hydrochloride | 12 | 1,008 | £1.2K | +1.4% vs avg |
| Rupatadine fumarate | 12 | 720 | £1.8K | +100.5% ▲ |
| Paracetamol combined preparations | 12 | 1,020 | £200 | +58.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.